Evolva Holding en liquidation (Evolva Holding en liquidation) Capex-to-Revenue : 0.46 (As of Jun. 2023)

Evolva Holding en liquidation Capex-to-Revenue Chart

Evolva Holding en liquidation Annual Data
	Trend	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22
Capex-to-Revenue		Get a 7-Day Free Trial					1.44	0.70	0.74	0.38	0.15

Evolva Holding en liquidation Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Capex-to-Revenue	Get a 7-Day Free Trial															0.44	0.27	0.15	0.14	0.46

Competitive Comparison of Evolva Holding en liquidation's Capex-to-Revenue

For the Biotechnology subindustry, Evolva Holding en liquidation's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Evolva Holding en liquidation's Capex-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Evolva Holding en liquidation's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Evolva Holding en liquidation's Capex-to-Revenue falls into.

Evolva Holding en liquidation Capex-to-Revenue Calculation

Evolva Holding en liquidation's Capex-to-Revenue for the fiscal year that ended in Dec. 2022 is calculated as

Evolva Holding en liquidation's Capex-to-Revenue for the quarter that ended in Jun. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Evolva Holding en liquidation  (OTCPK:ELVYY) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.

Evolva Holding en liquidation Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Evolva Holding en liquidation's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Evolva Holding en liquidation (Evolva Holding en liquidation) Business Description